FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283026733> ?p ?o ?g. }

• W4283026733 endingPage "1121" @default.
• W4283026733 startingPage "1121" @default.
• W4283026733 abstract "Background: Helicobacter pylori (H. pylori) infection causes gastritis, duodenal and gastric ulcers, and gastric cancer. H. pylori eradication efficacy is low worldwide, and antibiotic resistance is the leading cause of therapy failure; therefore, this study was performed to determine the characteristics of antibiotic resistance of H. pylori in children with gastritis, duodenal and gastric ulcer. Methods: A cross-sectional study was conducted on 237 pediatric patients diagnosed with gastroduodenal inflammation and ulcer at two hospitals in Vietnam from March 2019 to April 2022. Pediatric patients with positive H. pylori tests continued to do E-tests to measure the minimum inhibitory concentration of the antibiotic so that we could prescribe effective antibiotics based on the sensitivity. Results: In 237 pediatric patients (51.1% males) with a median age of 10.3 years (range 5–16 years), endoscopic images showed that inflammatory lesions and peptic ulcers accounted for 69.2% and 30.8%, respectively. Resistance rates of H. pylori were 80.6% to clarithromycin (CLR), 71.7% to amoxicillin (AMX), 49.4% to metronidazole (MTZ), 45.1% to levofloxacin (LEV), and 11.4% to tetracycline (TET); dual resistance to AMX + CLR was 64.2%, AMX + LEV 35%, AMX + MTZ 33.3%, CLR + MTZ 32.5%, and TET + MTZ 7.2%. The frequency of clarithromycin resistance was significantly increased, particularly in pediatric patients who had received prior H. pylori treatment. The percentage of amoxicillin resistance increased with age; amoxicillin resistance of H. pylori was more prevalent among pediatric patients with peptic ulcers than those with gastroduodenal inflammation and higher in males than females. Conclusions: The proportions of resistance to CLR, AMX, MTZ, and LEV were extremely high, in contrast to TET, which was lower in pediatric patients. Our study suggests that the standard triple therapy with CLR should be limited as the empiric therapy for pediatric patients, and we should consider using eradication regimens with TET for children over 8 years of age if the medical facility is not qualified to perform antibiotic susceptibility tests of H. pylori in the Mekong Delta." @default.
• W4283026733 created "2022-06-18" @default.
• W4283026733 creator A5018806889 @default.
• W4283026733 creator A5043653746 @default.
• W4283026733 creator A5055368957 @default.
• W4283026733 creator A5057386416 @default.
• W4283026733 creator A5061327624 @default.
• W4283026733 creator A5062468026 @default.
• W4283026733 creator A5076443968 @default.
• W4283026733 creator A5084080635 @default.
• W4283026733 date "2022-06-17" @default.
• W4283026733 modified "2023-09-26" @default.
• W4283026733 title "Antibiotic Resistance of Helicobacter pylori in Children with Gastritis and Peptic Ulcers in Mekong Delta, Vietnam" @default.
• W4283026733 cites W1485727351 @default.
• W4283026733 cites W1557722299 @default.
• W4283026733 cites W2068309369 @default.
• W4283026733 cites W2081018037 @default.
• W4283026733 cites W2121961138 @default.
• W4283026733 cites W2140716502 @default.
• W4283026733 cites W2158819521 @default.
• W4283026733 cites W2323517364 @default.
• W4283026733 cites W2339000330 @default.
• W4283026733 cites W2395518983 @default.
• W4283026733 cites W2472193147 @default.
• W4283026733 cites W2527848138 @default.
• W4283026733 cites W2604377831 @default.
• W4283026733 cites W2679057252 @default.
• W4283026733 cites W2735899764 @default.
• W4283026733 cites W2881320234 @default.
• W4283026733 cites W2887426516 @default.
• W4283026733 cites W2942710710 @default.
• W4283026733 cites W2986691695 @default.
• W4283026733 cites W3020867522 @default.
• W4283026733 cites W3023607209 @default.
• W4283026733 cites W3043817486 @default.
• W4283026733 cites W3122492776 @default.
• W4283026733 cites W3122734674 @default.
• W4283026733 cites W3180357950 @default.
• W4283026733 doi "https://doi.org/10.3390/healthcare10061121" @default.
• W4283026733 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35742177" @default.
• W4283026733 hasPublicationYear "2022" @default.
• W4283026733 type Work @default.
• W4283026733 citedByCount "7" @default.
• W4283026733 countsByYear W42830267332022 @default.
• W4283026733 countsByYear W42830267332023 @default.
• W4283026733 crossrefType "journal-article" @default.
• W4283026733 hasAuthorship W4283026733A5018806889 @default.
• W4283026733 hasAuthorship W4283026733A5043653746 @default.
• W4283026733 hasAuthorship W4283026733A5055368957 @default.
• W4283026733 hasAuthorship W4283026733A5057386416 @default.
• W4283026733 hasAuthorship W4283026733A5061327624 @default.
• W4283026733 hasAuthorship W4283026733A5062468026 @default.
• W4283026733 hasAuthorship W4283026733A5076443968 @default.
• W4283026733 hasAuthorship W4283026733A5084080635 @default.
• W4283026733 hasBestOaLocation W42830267331 @default.
• W4283026733 hasConcept C126322002 @default.
• W4283026733 hasConcept C2776409635 @default.
• W4283026733 hasConcept C2776962512 @default.
• W4283026733 hasConcept C2777396551 @default.
• W4283026733 hasConcept C2778677798 @default.
• W4283026733 hasConcept C2779390736 @default.
• W4283026733 hasConcept C2779708577 @default.
• W4283026733 hasConcept C2780561475 @default.
• W4283026733 hasConcept C2780656511 @default.
• W4283026733 hasConcept C2781276175 @default.
• W4283026733 hasConcept C501593827 @default.
• W4283026733 hasConcept C71924100 @default.
• W4283026733 hasConcept C86803240 @default.
• W4283026733 hasConcept C89423630 @default.
• W4283026733 hasConcept C90924648 @default.
• W4283026733 hasConcept C94665300 @default.
• W4283026733 hasConceptScore W4283026733C126322002 @default.
• W4283026733 hasConceptScore W4283026733C2776409635 @default.
• W4283026733 hasConceptScore W4283026733C2776962512 @default.
• W4283026733 hasConceptScore W4283026733C2777396551 @default.
• W4283026733 hasConceptScore W4283026733C2778677798 @default.
• W4283026733 hasConceptScore W4283026733C2779390736 @default.
• W4283026733 hasConceptScore W4283026733C2779708577 @default.
• W4283026733 hasConceptScore W4283026733C2780561475 @default.
• W4283026733 hasConceptScore W4283026733C2780656511 @default.
• W4283026733 hasConceptScore W4283026733C2781276175 @default.
• W4283026733 hasConceptScore W4283026733C501593827 @default.
• W4283026733 hasConceptScore W4283026733C71924100 @default.
• W4283026733 hasConceptScore W4283026733C86803240 @default.
• W4283026733 hasConceptScore W4283026733C89423630 @default.
• W4283026733 hasConceptScore W4283026733C90924648 @default.
• W4283026733 hasConceptScore W4283026733C94665300 @default.
• W4283026733 hasIssue "6" @default.
• W4283026733 hasLocation W42830267331 @default.
• W4283026733 hasLocation W42830267332 @default.
• W4283026733 hasLocation W42830267333 @default.
• W4283026733 hasOpenAccess W4283026733 @default.
• W4283026733 hasPrimaryLocation W42830267331 @default.
• W4283026733 hasRelatedWork W1970761867 @default.
• W4283026733 hasRelatedWork W2347253155 @default.
• W4283026733 hasRelatedWork W2349950450 @default.
• W4283026733 hasRelatedWork W2380622414 @default.
• W4283026733 hasRelatedWork W2790297549 @default.

• next